NewsCheck our calendar
PRESS RELEASE – BLIRT CHANGES OWNERS; 96% OF THE COMPANY’S SHARES ACQUIRED BY QIAGEN
Gdańsk, 11 May 2022 PRESS RELEASE BLIRT CHANGES OWNERS 96% OF THE COMPANY’S SHARES ACQUIRED BY QIAGEN BLIRT SA, a biotech firm specializing in producing high-quality enzymes and reagents used … Continue reading “PRESS RELEASE – BLIRT CHANGES OWNERS; 96% OF THE COMPANY’S SHARES ACQUIRED BY QIAGEN”
Biotechnology opens up new horizons
A series about the economic situation of Pomerania – a weekly TV program hosted Vice-President of the Management Board at BLIRT, Tomasz Wrzesiński, who referred to the development of biotechnology: … Continue reading “Biotechnology opens up new horizons”
Expanding the laboratory facilities
BLIRT has signed a contract to expand the laboratory facility at Gdansk Science and Technology Park. We produce the highest quality recombinant enzymes and reagents dedicated to the Life Science … Continue reading “Expanding the laboratory facilities”
Are there bacteria in the stratosphere? Check The Stardust project.
Are there bacteria in the stratosphere? What mechanisms allow them to obtain resistance to high doses of UV and ionizing radiation? Bartosz Rybacki – our apprentice this year, is … Continue reading “Are there bacteria in the stratosphere? Check The Stardust project.”
BLIRT is ISO 13485:2016 certified!
We are honored to announce that BLIRT has been awarded ISO 13485:2016 Quality Management System certification from Lloyd’s Register. The ISO 13485:2016 certificate covers the entire activity of the company … Continue reading “BLIRT is ISO 13485:2016 certified!”
Blirt became a Registered Exporter
Blirt has become a registered exporter and received a REX number. The Registered Exporter System (the REX system) is a certification system of origin of goods based on a principle … Continue reading “Blirt became a Registered Exporter”